Mathieu Ferrari

1.4k total citations
27 papers, 278 citations indexed

About

Mathieu Ferrari is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Mathieu Ferrari has authored 27 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Mathieu Ferrari's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and CAR-T cell therapy research (6 papers). Mathieu Ferrari is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and CAR-T cell therapy research (6 papers). Mathieu Ferrari collaborates with scholars based in United Kingdom, Italy and United States. Mathieu Ferrari's co-authors include Shimobi Onuoha, Costantino Pitzalis, Martin Pulé, Daniele Sblattero, Laura Andréoli, Roberta Cattaneo Horn, Silvana Archetti, M. Taraborelli, Anǵela Tincani and Reyisa Bughda and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Mathieu Ferrari

26 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Ferrari United Kingdom 11 81 71 70 69 64 27 278
Brian Whitaker United States 9 121 1.5× 41 0.6× 126 1.8× 126 1.8× 58 0.9× 11 348
Iga Janowska Germany 8 118 1.5× 48 0.7× 58 0.8× 24 0.3× 38 0.6× 14 236
William Loo United States 9 249 3.1× 79 1.1× 68 1.0× 56 0.8× 33 0.5× 11 382
Louise Saul United Kingdom 9 143 1.8× 22 0.3× 78 1.1× 45 0.7× 48 0.8× 12 334
Natalia Sherina Sweden 8 37 0.5× 167 2.4× 102 1.5× 40 0.6× 43 0.7× 15 360
Abhishek Saxena Netherlands 8 109 1.3× 20 0.3× 120 1.7× 150 2.2× 86 1.3× 12 452
Shinichiro Takezaki Japan 12 135 1.7× 41 0.6× 43 0.6× 60 0.9× 44 0.7× 21 426
Wen‐Chuan Hsieh Taiwan 10 84 1.0× 32 0.5× 86 1.2× 15 0.2× 53 0.8× 19 306
Andrea Reitsma Australia 6 120 1.5× 53 0.7× 31 0.4× 43 0.6× 29 0.5× 8 240
Tihomir Dodev United Kingdom 11 215 2.7× 66 0.9× 105 1.5× 151 2.2× 72 1.1× 13 462

Countries citing papers authored by Mathieu Ferrari

Since Specialization
Citations

This map shows the geographic impact of Mathieu Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Ferrari more than expected).

Fields of papers citing papers by Mathieu Ferrari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Ferrari. The network helps show where Mathieu Ferrari may publish in the future.

Co-authorship network of co-authors of Mathieu Ferrari

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Ferrari. A scholar is included among the top collaborators of Mathieu Ferrari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Ferrari. Mathieu Ferrari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horna, Pedro, Mathieu Ferrari, Gregory E. Otteson, et al.. (2024). Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood Cancer Journal. 14(1). 34–34. 13 indexed citations
2.
Hotblack, Alastair, Reyisa Bughda, Anna Bulek, et al.. (2024). Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein–Protein Interaction. ACS Chemical Biology. 19(2). 308–324. 4 indexed citations
3.
Bulek, Anna, Mathew Robson, Evangelia Kokalaki, et al.. (2023). Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2. Frontiers in Immunology. 14. 1119350–1119350. 3 indexed citations
4.
Mekkaoui, Leila, Emma Bentley, Mathieu Ferrari, et al.. (2021). Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike. BIO-PROTOCOL. 11(16). e4194–e4194. 3 indexed citations
5.
Ferrari, Mathieu, Shimobi Onuoha, Liliane Fossati‐Jimack, et al.. (2021). Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis. Frontiers in Immunology. 12. 640070–640070. 13 indexed citations
6.
Ferrari, Mathieu, Emma Bentley, Giada Mattiuzzo, et al.. (2021). A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency. Antiviral Research. 194. 105147–105147. 11 indexed citations
7.
Nannini, Francesco, Patrycja Wawrzyniecka, Mathieu Ferrari, et al.. (2021). Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL). Blood. 138(Supplement 1). 902–902. 7 indexed citations
8.
Nannini, Francesco, Patrycja Wawrzyniecka, Leila Mekkaoui, et al.. (2020). A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats. Scientific Reports. 10(1). 19168–19168. 4 indexed citations
9.
Peruta, Marco Della, Mathew Robson, Philip Fei Wu, et al.. (2020). Abstract 1070: AUTO7: Anti-PSMA humanized CAR T-cell with improved persistence and resistance to tumor microenvironment for metastatic castration resistant prostate cancer (mCRPC). Cancer Research. 80(16_Supplement). 1070–1070. 1 indexed citations
10.
Nannini, Francesco, Reyisa Bughda, James Sillibourne, et al.. (2020). Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments. mAbs. 13(1). 1864084–1864084. 16 indexed citations
11.
Thomas, Simon, Vania Baldan, Evangelia Kokalaki, et al.. (2017). A DUAL TARGETING CAR‐T CELL APPROACH FOR THE TREATMENT OF B CELL MALIGNANCIES. Hematological Oncology. 35(S2). 261–261. 1 indexed citations
12.
Ferrari, Mathieu, Shimobi Onuoha, & Costantino Pitzalis. (2015). Trojan horses and guided missiles: targeted therapies in the war on arthritis. Nature Reviews Rheumatology. 11(6). 328–337. 53 indexed citations
13.
Ferrari, Mathieu, Shimobi Onuoha, & Costantino Pitzalis. (2015). Going with the flow: harnessing the power of the vasculature for targeted therapy in rheumatoid arthritis. Drug Discovery Today. 21(1). 172–179. 13 indexed citations
14.
Ferrari, Mathieu, Stanley Chukwudozie Onuoha, Daniele Sblattero, & Costantino Pitzalis. (2015). FRI0103 Synovial Specific Prodrug for the Next Generation of Anti-TNF Therapy in Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 74. 456–457. 1 indexed citations
15.
Onuoha, Shimobi, Mathieu Ferrari, Daniele Sblattero, & Costantino Pitzalis. (2015). Rational Design of Antirheumatic Prodrugs Specific for Sites of Inflammation. Arthritis & Rheumatology. 67(10). 2661–2672. 17 indexed citations
16.
Taraborelli, M., Laura Andréoli, Silvana Archetti, et al.. (2011). Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience. Reumatismo. 61(2). 98–106. 1 indexed citations
17.
Kamalati, Tahereh, Mathieu Ferrari, Margaret T. Jones, et al.. (2011). Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis. Arthritis & Rheumatism. 63(12). 3758–3767. 13 indexed citations
18.
Taraborelli, M., Laura Andréoli, Silvana Archetti, et al.. (2009). Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients.. PubMed. 27(3). 499–502. 26 indexed citations
19.
Ferrari, Mathieu, et al.. (1994). BAEP and E.M.G. changes from whiplash injuries.. PubMed. 16(5-6). 262–70. 7 indexed citations
20.
Ceserani, R., et al.. (1983). FCE 20700, a cytoprotective PGE2 derivative, does not interfere with the antiinflammatory activity of indomethacin.. PubMed. 5(4). 349–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Whitaker Breakdown of academic impact, for papers by Iga Janowska Breakdown of academic impact, for papers by William Loo Breakdown of academic impact, for papers by Louise Saul Breakdown of academic impact, for papers by Natalia Sherina Breakdown of academic impact, for papers by Abhishek Saxena Breakdown of academic impact, for papers by Shinichiro Takezaki Breakdown of academic impact, for papers by Wen‐Chuan Hsieh Breakdown of academic impact, for papers by Andrea Reitsma Breakdown of academic impact, for papers by Tihomir Dodev
Rankless by CCL
2026